mhurhangee/patent-ind-claim-en huggingface dataset:
A system comprising: a product line configured to move products through a facility; a printer arranged in proximity to at least a portion of the product line, the printer configured to mark the products moved through the facility on the product line with product codes using a single ink comprising a combination of a non-fluorescing substance and an ultraviolet, i.e., UV, fluorescing substance, wherein the UV fluorescing substance is selected to fluoresce at a specified visible light wavelength based on the background of the products; a UV light source configured and arranged to illuminate the product codes printed on the products with UV light, wherein the UV light source is positioned relative to the product line to illuminate the product codes printed on the products ; a camera configured and arranged to capture visible light emitted by the single ink of the product codes responsive to the illumination with the UV light to capture images of the product codes; and a controller coupled with the camera and configured to perform machine vision processing on the captured images to identify the product codes in the captured images and confirm that the product codes printed on the products match expected product codes, using an increased contrast ratio between the product codes and the background of the products resulting from the fluorescing of the ink in response to the UV light. a product line configured to move products through a facility; a printer arranged in proximity to at least a portion of the product line, the printer configured to mark the products moved through the facility on the product line with product codes using a single ink comprising a combination of a non-fluorescing substance and an ultraviolet, i.e., UV, fluorescing substance, wherein the UV fluorescing substance is selected to fluoresce at a specified visible light wavelength based on the background of the products; a UV light source configured and arranged to illuminate the product codes printed on the products with UV light, wherein the UV light source is positioned relative to the product line to illuminate the product codes printed on the products ; a camera configured and arranged to capture visible light emitted by the single ink of the product codes responsive to the illumination with the UV light to capture images of the product codes; and a controller coupled with the camera and configured to perform machine vision processing on the captured images to identify the product codes in the captured images and confirm that the product codes printed on the products match expected product codes, using an increased contrast ratio between the product codes and the background of the products resulting from the fluorescing of the ink in response to the UV light.
A sealing ring for a pipe assembly having a cross-sectional shape comprising: a plane surface , defining a plane (P) of the sealing ring, an essentially planar, slanting surface being at a first angle (α) to the plane (P) of the sealing ring , and a groove surface , interconnecting the plane surface and the slanting surface , the groove surface opposing the slanting surface and having a curvature such that it is connected to the slanting surface , and an abutment surface opposing the groove surface and interconnecting the slanting surface and the plane surface , characterized in that the abutment surface comprises a curve defining the interconnection between the slanting surface and the plane surface , wherein the angle of the abutment surface to the plane (P) varies along the abutment surface from the first angel (α) to a second angle (β) that is smaller than the first angle (α). a plane surface , defining a plane (P) of the sealing ring, an essentially planar, slanting surface being at a first angle (α) to the plane (P) of the sealing ring , and a groove surface , interconnecting the plane surface and the slanting surface , the groove surface opposing the slanting surface and having a curvature such that it is connected to the slanting surface , and an abutment surface opposing the groove surface and interconnecting the slanting surface and the plane surface , characterized in that the abutment surface comprises a curve defining the interconnection between the slanting surface and the plane surface , wherein the angle of the abutment surface to the plane (P) varies along the abutment surface from the first angel (α) to a second angle (β) that is smaller than the first angle (α).
A display device comprising: a plurality of organic light-emitting diode (OLED) pixels on a first substrate; and a plurality of light-emitting diode (LED)-including pixels between the plurality of OLED pixels; wherein the plurality of LED-including pixels comprise a backlight unit and a liquid crystal layer configured to allow the light from the backlight unit to pass therethrough; and characterised in that the backlight unit comprises an LED light source, the plurality of OLED pixels are configured to emit red, green and blue light, and the plurality of LED-including pixels are configured to emit blue light. a plurality of organic light-emitting diode (OLED) pixels on a first substrate; and a plurality of light-emitting diode (LED)-including pixels between the plurality of OLED pixels; wherein the plurality of LED-including pixels comprise a backlight unit and a liquid crystal layer configured to allow the light from the backlight unit to pass therethrough; and characterised in that the backlight unit comprises an LED light source, the plurality of OLED pixels are configured to emit red, green and blue light, and the plurality of LED-including pixels are configured to emit blue light.
Method for operating a container treatment machine for treating containers with a treatment fluid , e.g. a container cleaning machine, in which container treatment machine operating parameters, such as, for example, the temperature of the treatment fluid and the duration of the treatment of the containers with the treatment fluid can be set, wherein, for the treatment of the containers, the container type to be treated and/or the degree of soiling of the containers to be treated is/are detected and at least one operating parameter is set as a dependency of the container type and/or the degree of soiling, characterised in that , for the restarting of the container treatment machine after temporary disconnection, the treatment fluid is heated before the restart, such that, at the time of restart, a predetermined operating temperature has at least approximately been attained, and that a controller of the container treatment machine is provided before the restart with data regarding the container type to be treated, from which the controller calculates the operating parameters of the container treatment machine for this container type and the assigned heating time for the treatment fluid , and the heating of the treatment fluid is started a corresponding period of time before the restart of the container treatment machine.
An image display apparatus comprising: an imager (RL, RR) configured to image a scene in rear side surroundings of a vehicle ; a display configured to display a captured image imaged by said imager (RL, RR); and a display controller configured to switch between a first display mode in which a first image is displayed and a second display mode in which a second image is displayed, wherein the first image is the captured image showing a first range out of the rear side surroundings of the vehicle , characterised in that : the second image is the captured image including the first range and showing a second range, which is wider than the first range, out of the rear side surroundings of the vehicle , and in that said display controller is configured to display the second image on said display in an aspect of clearly showing an area of the second image corresponding to the first image, in the second display mode. an imager (RL, RR) configured to image a scene in rear side surroundings of a vehicle ; a display configured to display a captured image imaged by said imager (RL, RR); and a display controller configured to switch between a first display mode in which a first image is displayed and a second display mode in which a second image is displayed, wherein the first image is the captured image showing a first range out of the rear side surroundings of the vehicle , characterised in that : the second image is the captured image including the first range and showing a second range, which is wider than the first range, out of the rear side surroundings of the vehicle , and in that said display controller is configured to display the second image on said display in an aspect of clearly showing an area of the second image corresponding to the first image, in the second display mode. the second image is the captured image including the first range and showing a second range, which is wider than the first range, out of the rear side surroundings of the vehicle , and in that said display controller is configured to display the second image on said display in an aspect of clearly showing an area of the second image corresponding to the first image, in the second display mode.
A nutritional composition comprising at least one peptide having a length of from five to twelve amino acids that comprises a sequence chosen from SEQ ID No.3-4, and TGF-β; wherein the at least one peptide are eight peptides, each one comprising a different sequence chosen from SEQ ID No.1-8, and having a length of from five to twelve amino acids for use in the induction and maintenance of oral tolerance to BLG and the maintenance of the oral tolerance to other food proteins that has been acquired via the consumption of maternal milk in young mammals during and after the weaning period.
A lubricating composition, comprising: a) an oil of lubricating viscosity selected from the group consisting of a Group II base oil, a Group III base oil, a Group IV base oil, a Group V base oil, or mixtures thereof; and b) an antifoam component comprising a poly(acrylate) copolymer including: (i) from 75 wt% up to 90 wt% of an acrylate monomer having C4 to C8 alkyl esters of acrylic acid; and (ii) from 10 wt% up to 25 wt% of a comonomer having C2 to C3 alkyl esters of acrylic acid; the antifoam component having a M n of at least 13,000; and (c) a phosphorous-containing component comprising one or more of a phosphite, a phosphorus-containing amide, a phosphorus-containing carboxylic acid or ester, a phosphorus-containing ether, and mixtures and derivatives thereof. a) an oil of lubricating viscosity selected from the group consisting of a Group II base oil, a Group III base oil, a Group IV base oil, a Group V base oil, or mixtures thereof; and b) an antifoam component comprising a poly(acrylate) copolymer including: (i) from 75 wt% up to 90 wt% of an acrylate monomer having C4 to C8 alkyl esters of acrylic acid; and (ii) from 10 wt% up to 25 wt% of a comonomer having C2 to C3 alkyl esters of acrylic acid; the antifoam component having a M n of at least 13,000; and (i) from 75 wt% up to 90 wt% of an acrylate monomer having C4 to C8 alkyl esters of acrylic acid; and (ii) from 10 wt% up to 25 wt% of a comonomer having C2 to C3 alkyl esters of acrylic acid; (c) a phosphorous-containing component comprising one or more of a phosphite, a phosphorus-containing amide, a phosphorus-containing carboxylic acid or ester, a phosphorus-containing ether, and mixtures and derivatives thereof.
A compound of Formula (III), or a pharmaceutically acceptable salt thereof: wherein: R 2 is F, Cl, OH, NH 2 , CN, and N 3 ; R 3 is selected from the group of CN, N 3 , methyl, ethyl, propyl, vinyl, propenyl, ethynyl, CH 2 F, CHF 2 , CH 2 Cl, CH 2 SMe, and CH 2 OMe; and R 4 is (a) a group of the formula: wherein W 1 and W 2 are each, independently, OH or a group of the Formula Ia: wherein: each Y is independently a bond or O; m is 0, 1, 2, or 3; each R x is H, halogen or OH; or (b) selected from: wherein: n' is selected from 1, 2, 3, and 4; R 7 is selected from C 1 -C 8 alkyl, -O-C 1 -C 8 alkyl, benzyl, -O-benzyl, -CH 2 -C 3 -C 6 cycloalkyl, -O-CH 2 -C 3 -C 6 cycloalkyl, and CF 3 ; R 8 is selected from phenyl, 1-naphthyl, 2-naphthyl, R 9 is selected from H and CH 3 ; R 10 is selected from H or C 1 -C 6 alkyl; R 11 is selected from H, C 1 -C 8 alkyl, benzyl, C 3 -C 6 cycloalkyl, and -CH 2 -C 3 -C 6 cycloalkyl. R 2 is F, Cl, OH, NH 2 , CN, and N 3 ; R 3 is selected from the group of CN, N 3 , methyl, ethyl, propyl, vinyl, propenyl, ethynyl, CH 2 F, CHF 2 , CH 2 Cl, CH 2 SMe, and CH 2 OMe; and R 4 is (a) a group of the formula: wherein W 1 and W 2 are each, independently, OH or a group of the Formula Ia: wherein: each Y is independently a bond or O; m is 0, 1, 2, or 3; each R x is H, halogen or OH; or (b) selected from: wherein: n' is selected from 1, 2, 3, and 4; R 7 is selected from C 1 -C 8 alkyl, -O-C 1 -C 8 alkyl, benzyl, -O-benzyl, -CH 2 -C 3 -C 6 cycloalkyl, -O-CH 2 -C 3 -C 6 cycloalkyl, and CF 3 ; R 8 is selected from phenyl, 1-naphthyl, 2-naphthyl, R 9 is selected from H and CH 3 ; R 10 is selected from H or C 1 -C 6 alkyl; R 11 is selected from H, C 1 -C 8 alkyl, benzyl, C 3 -C 6 cycloalkyl, and -CH 2 -C 3 -C 6 cycloalkyl. (a) a group of the formula: wherein W 1 and W 2 are each, independently, OH or a group of the Formula Ia: wherein: each Y is independently a bond or O; m is 0, 1, 2, or 3; each R x is H, halogen or OH; or each Y is independently a bond or O; m is 0, 1, 2, or 3; each R x is H, halogen or OH; or (b) selected from: wherein: n' is selected from 1, 2, 3, and 4; R 7 is selected from C 1 -C 8 alkyl, -O-C 1 -C 8 alkyl, benzyl, -O-benzyl, -CH 2 -C 3 -C 6 cycloalkyl, -O-CH 2 -C 3 -C 6 cycloalkyl, and CF 3 ; R 8 is selected from phenyl, 1-naphthyl, 2-naphthyl, R 9 is selected from H and CH 3 ; R 10 is selected from H or C 1 -C 6 alkyl; R 11 is selected from H, C 1 -C 8 alkyl, benzyl, C 3 -C 6 cycloalkyl, and -CH 2 -C 3 -C 6 cycloalkyl. n' is selected from 1, 2, 3, and 4; R 7 is selected from C 1 -C 8 alkyl, -O-C 1 -C 8 alkyl, benzyl, -O-benzyl, -CH 2 -C 3 -C 6 cycloalkyl, -O-CH 2 -C 3 -C 6 cycloalkyl, and CF 3 ; R 8 is selected from phenyl, 1-naphthyl, 2-naphthyl, R 9 is selected from H and CH 3 ; R 10 is selected from H or C 1 -C 6 alkyl; R 11 is selected from H, C 1 -C 8 alkyl, benzyl, C 3 -C 6 cycloalkyl, and -CH 2 -C 3 -C 6 cycloalkyl.
Pharmaceutically acceptable, rapidly dispersing microgranules having a median particle size in the range of 100 μm to 300 μm and comprising at least one sugar alcohol, saccharide, or a mixture thereof, at least one super disintegrant selected from the group consisting of crospovidone, croscarmellose sodium, sodium starch glycolate, low-substituted hydroxypropylcellulose and mixtures thereof, and pregelatinized starch in an amount of 0.5-3.0% by weight, wherein the rapidly dispersing microgranules do not comprise a pharmaceutically active agent.
A delivery system for delivering colostrum or milk to an infant, the system comprising: a plurality of syringes for delivering a dose of colostrum or milk, the total volume of each syringe is about 1.0 mL or less; and a storage container for storing the plurality of syringes having the colostrum or milk therein, preferably the storage container comprising a cover . a plurality of syringes for delivering a dose of colostrum or milk, the total volume of each syringe is about 1.0 mL or less; and a storage container for storing the plurality of syringes having the colostrum or milk therein, preferably the storage container comprising a cover .
A microfluidic device comprising: a microfluidic cartridge comprising at least one fluidic conduit , and a plurality of fluidic wells at least one of which comprises magnetic beads; a top actuation element and a bottom actuation element , each actuation element comprising permanent magnets and protrusions, the permanent magnets and protrusions being spatially arranged on each actuation element such that they perform sequential steps of an assay; the microfluidic cartridge being sandwiched between top and bottom actuation elements; wherein the microfluidic cartridge and/or the top actuation element and the bottom actuation element are adapted for rotational or linear movement relative to one another thereby moving said magnetic beads between fluidic wells by interaction between said permanent magnets and said magnetic beads. a microfluidic cartridge comprising at least one fluidic conduit , and a plurality of fluidic wells at least one of which comprises magnetic beads; a top actuation element and a bottom actuation element , each actuation element comprising permanent magnets and protrusions, the permanent magnets and protrusions being spatially arranged on each actuation element such that they perform sequential steps of an assay; the microfluidic cartridge being sandwiched between top and bottom actuation elements; wherein the microfluidic cartridge and/or the top actuation element and the bottom actuation element are adapted for rotational or linear movement relative to one another thereby moving said magnetic beads between fluidic wells by interaction between said permanent magnets and said magnetic beads.
A computer-implemented method comprising: receiving three-dimensional seismic image data acquired by sensors in a geological environment; extracting orthogonal intersections through the three-dimensional image data in the inline, crossline and vertical planes to generate a plurality of two-dimensional planes of the three-dimensional seismic image data; calculating shape index values SI for each pixel of the image data along each of the plurality of two-dimensional planes; applying a function to determine a shape likelihood value SL indicating the likelihood that the calculated shape index value SI for any pixel of the image data along a two-dimensional plane is of a desired shape value f, wherein the function comprises: SL f SI = 1 − 2 * MIN 1 2 f − SI where SL is the shape likelihood value, SI is the calculated shape index value for a given pixel in the two-dimensional plane and f is the desired shape value in a range -1.0 to +1.0 ; and classifying multi-dimensional features in the three-dimensional seismic image data based at least in part on the determined shape likelihood values. receiving three-dimensional seismic image data acquired by sensors in a geological environment; extracting orthogonal intersections through the three-dimensional image data in the inline, crossline and vertical planes to generate a plurality of two-dimensional planes of the three-dimensional seismic image data; calculating shape index values SI for each pixel of the image data along each of the plurality of two-dimensional planes; applying a function to determine a shape likelihood value SL indicating the likelihood that the calculated shape index value SI for any pixel of the image data along a two-dimensional plane is of a desired shape value f, wherein the function comprises: SL f SI = 1 − 2 * MIN 1 2 f − SI where SL is the shape likelihood value, SI is the calculated shape index value for a given pixel in the two-dimensional plane and f is the desired shape value in a range -1.0 to +1.0 ; and classifying multi-dimensional features in the three-dimensional seismic image data based at least in part on the determined shape likelihood values.
A surgical implant for maintaining the position of a female patient's urethra, characterised in that the implant comprises: (a) a proximal portion having a width, length, and thickness, the width of the proximal portion being 12 cm ± 20% and the length of the proximal portion being 1.9 cm ± 20% , the proximal portion comprising a first non-absorbable biocompatible material; and (b) a distal portion having a width, length, and thickness, the width of the distal portion being 2 cm ± 20%, and the length of the distal portion being 1.9 cm ± 20%, the distal portion comprising a second non-absorbable biocompatible material. (a) a proximal portion having a width, length, and thickness, the width of the proximal portion being 12 cm ± 20% and the length of the proximal portion being 1.9 cm ± 20% , the proximal portion comprising a first non-absorbable biocompatible material; and (b) a distal portion having a width, length, and thickness, the width of the distal portion being 2 cm ± 20%, and the length of the distal portion being 1.9 cm ± 20%, the distal portion comprising a second non-absorbable biocompatible material.
A pharmaceutical composition comprising, in relation to 100% by weight of a total amount of a self-emulsifying composition: a) 70 to 90% by weight of eicosapentaenoic acid ethyl ester as a first medicinal component; b) 0.5 to 6% by weight of water; c) 1 to 29% by weight of (i) polyoxyethylene sorbitan fatty acid ester and (ii) polyoxyethylene hydrogenated castor oil and/or polyoxyethylene castor oil as emulsifiers; d) 1 to 25 parts by weight of lecithin in relation to 100 parts by weight of the eicosapentaenoic acid ethyl ester; and e) pitavastatin, rosuvastatin, or a salt thereof as a second medicinal component, wherein f) ethanol constitutes up to 4% by weight of the total amount of the self-emulsifying composition, and g) polyhydric alcohol constitutes up to 4% by weight of the total amount of the self-emulsifying composition. a) 70 to 90% by weight of eicosapentaenoic acid ethyl ester as a first medicinal component; b) 0.5 to 6% by weight of water; c) 1 to 29% by weight of (i) polyoxyethylene sorbitan fatty acid ester and (ii) polyoxyethylene hydrogenated castor oil and/or polyoxyethylene castor oil as emulsifiers; (i) polyoxyethylene sorbitan fatty acid ester and (ii) polyoxyethylene hydrogenated castor oil and/or polyoxyethylene castor oil as emulsifiers; d) 1 to 25 parts by weight of lecithin in relation to 100 parts by weight of the eicosapentaenoic acid ethyl ester; and e) pitavastatin, rosuvastatin, or a salt thereof as a second medicinal component, f) ethanol constitutes up to 4% by weight of the total amount of the self-emulsifying composition, and g) polyhydric alcohol constitutes up to 4% by weight of the total amount of the self-emulsifying composition.